253 related articles for article (PubMed ID: 22226688)
1. Changes in intracortical microporosities induced by pharmaceutical treatment of osteoporosis as detected by high resolution micro-CT.
Tommasini SM; Trinward A; Acerbo AS; De Carlo F; Miller LM; Judex S
Bone; 2012 Mar; 50(3):596-604. PubMed ID: 22226688
[TBL] [Abstract][Full Text] [Related]
2. Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass.
Amugongo SK; Yao W; Jia J; Lay YA; Dai W; Jiang L; Walsh D; Li CS; Dave NK; Olivera D; Panganiban B; Ritchie RO; Lane NE
Osteoporos Int; 2014 Jun; 25(6):1735-50. PubMed ID: 24722767
[TBL] [Abstract][Full Text] [Related]
3. Once-weekly parathyroid hormone combined with ongoing long-term alendronate treatment promotes osteoporotic fracture healing in ovariectomized rats.
Zhang C; Zhu J; Jia J; Guan Z; Sun T; Zhang W; Yuan W; Wang H; Leng H; Song C
J Orthop Res; 2021 Oct; 39(10):2103-2115. PubMed ID: 33325546
[TBL] [Abstract][Full Text] [Related]
4. Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents.
Shahnazari M; Yao W; Wang B; Panganiban B; Ritchie RO; Hagar Y; Lane NE
J Bone Miner Res; 2011 Mar; 26(3):569-81. PubMed ID: 20839286
[TBL] [Abstract][Full Text] [Related]
5. A closer look at the immediate trabecula response to combined parathyroid hormone and alendronate treatment.
Altman AR; Tseng WJ; de Bakker CM; Huh BK; Chandra A; Qin L; Liu XS
Bone; 2014 Apr; 61():149-57. PubMed ID: 24468717
[TBL] [Abstract][Full Text] [Related]
6. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
Li X; Ominsky MS; Warmington KS; Niu QT; Asuncion FJ; Barrero M; Dwyer D; Grisanti M; Stolina M; Kostenuik PJ; Simonet WS; Paszty C; Ke HZ
Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
[TBL] [Abstract][Full Text] [Related]
7. Sequential Treatment of Estrogen Deficient, Osteopenic Rats with Alendronate, Parathyroid Hormone (1-34), or Raloxifene Alters Cortical Bone Mineral and Matrix Composition.
Taylor EA; Donnelly E; Yao X; Johnson ML; Amugongo SK; Kimmel DB; Lane NE
Calcif Tissue Int; 2020 Mar; 106(3):303-314. PubMed ID: 31784772
[TBL] [Abstract][Full Text] [Related]
8. Differing Effects of Parathyroid Hormone, Alendronate, and Odanacatib on Bone Formation and on the Mineralization Process in Intracortical and Endocortical Bone of Ovariectomized Rabbits.
Vrahnas C; Buenzli PR; Pearson TA; Pennypacker BL; Tobin MJ; Bambery KR; Duong LT; Sims NA
Calcif Tissue Int; 2018 Dec; 103(6):625-637. PubMed ID: 30019315
[TBL] [Abstract][Full Text] [Related]
9. Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats.
Luo Y; Zhang L; Wang WY; Hu QF; Song HP; Su YL; Zhang YZ
Bone; 2013 Aug; 55(2):439-48. PubMed ID: 23500174
[TBL] [Abstract][Full Text] [Related]
10. Intermittent Parathyroid Hormone After Prolonged Alendronate Treatment Induces Substantial New Bone Formation and Increases Bone Tissue Heterogeneity in Ovariectomized Rats.
Altman-Singles AR; Jeong Y; Tseng WJ; de Bakker CM; Zhao H; Lott C; Robberts J; Qin L; Han L; Kim DG; Liu XS
J Bone Miner Res; 2017 Aug; 32(8):1703-1715. PubMed ID: 28467646
[TBL] [Abstract][Full Text] [Related]
11. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
13. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
[TBL] [Abstract][Full Text] [Related]
14. The bone architecture is enhanced with combined PTH and alendronate treatment compared to monotherapy while maintaining the state of surface mineralization in the OVX rat.
Campbell GM; Bernhardt R; Scharnweber D; Boyd SK
Bone; 2011 Aug; 49(2):225-32. PubMed ID: 21515436
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined elcatonin and alendronate treatment on the architecture and strength of bone in ovariectomized rats.
Ogawa K; Hori M; Takao R; Sakurada T
J Bone Miner Metab; 2005; 23(5):351-8. PubMed ID: 16133684
[TBL] [Abstract][Full Text] [Related]
17. Mechanical competence of ovariectomy-induced compromised bone after single or combined treatment with high-frequency loading and bisphosphonates.
Camargos GV; Bhattacharya P; van Lenthe GH; Del Bel Cury AA; Naert I; Duyck J; Vandamme K
Sci Rep; 2015 Jun; 5():10795. PubMed ID: 26027958
[TBL] [Abstract][Full Text] [Related]
18. Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?
Correa CB; Camargos GV; Chatterjee M; Mesquita MF; Del Bel Cury AA; Naert I; Duyck J; Vandamme K
Osteoporos Int; 2017 Apr; 28(4):1287-1293. PubMed ID: 27921147
[TBL] [Abstract][Full Text] [Related]
19. Effects of alendronate and strontium ranelate on cancellous and cortical bone mass in glucocorticoid-treated adult rats.
Sun P; Cai DH; Li QN; Chen H; Deng WM; He L; Yang L
Calcif Tissue Int; 2010 Jun; 86(6):495-501. PubMed ID: 20390406
[TBL] [Abstract][Full Text] [Related]
20. Comparable effects of alendronate and strontium ranelate on femur in ovariectomized rats.
Chen B; Li Y; Yang X; Xie D
Calcif Tissue Int; 2013 Nov; 93(5):481-6. PubMed ID: 23897224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
